Third, we identified two molecular mechanisms by which STAT3 inhibition may directly impact parenchymal and vascular amyloid pathogenesis—reduction in BACE1 activity and restoration of brain levels of LRP-1. This evidence concerns the gene STAT3 and amyloidosis.